SensNews March 2020

Sensor100 Page 9 SD Biosensor bio-diagnostic company near Cheongju, South Korea. COVID-19 test kits pour off production line. The kits are already exported to eight coun- tries including UAE, Germany, India and Italy. Nearly 120 countries are now seeking to secure South Korean-made test kits, either as purchases or humanitarian aid. Seoul was prioritising the US, United Arab Emirates and Indonesia. Gulf News 30 March bioMérieux receives Emergency Use Authorization for BIOFIRE® COVID-19 test bioMérieux, a world leader in the field of in vitro diagnostics, announced that its subsid- iary, BioFire Defense, has received Emergency Use Authorization by the U.S. Food and Drug Administration of its BIOFIRE® COVID-19 test for use in CLIA moderate and high complexity clinical laboratories to detect SARS-CoV-2. The BIOFIRE® COVID-19 test detects SARS-CoV-2 in approximately 45 minutes from a nasopharyngeal swab in trans- port media.This test runs on the fully automated FILMARRAY® 2.0 and FILMARRAY® TORCH platforms and is extremely easy to use, therefore requiring minimal training and skills in molecular biology. bioMerieux 24 March Scammers are going door-to-door pretending to be from the US Centers for Disease Control and Prevention to sell COVID-19 tests, Mother Jones reports. Additionally, the US Food and Drug Adminis- tration has warned consumers about fraudulent at-home COVID-19 testing kits, as 360Dx reports, noting that FDA has not authorized any at-home test kits. GenomeWeb 2 4 March